可操作性
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
清脆的
2019年冠状病毒病(COVID-19)
检出限
计算生物学
病毒学
核酸
2019-20冠状病毒爆发
生物
计算机科学
医学
化学
遗传学
色谱法
基因
病理
疾病
爆发
软件工程
传染病(医学专业)
作者
Gong‐Jian Tang,Zilong Zhang,Winson Jianhong Tan,Fei Long,Jiangtao Sun,Yingying Li,Siwei Zou,Yujiao Yang,Kezhu Cai,Shenwei Li,Zhiyi Wang,Jiakun Liu,Guobing Mao,Yingxin Ma,Guoping Zhao,Zhengan Tian,Wei Zhao
标识
DOI:10.1016/j.snb.2023.133433
摘要
Timely and accurate detection of SARS-CoV-2 variants of concern (VOCs) is urgently needed for pandemic surveillance and control. Great efforts have been made from a mass of scientists in increasing the detection sensitivity and operability, and reducing the turn-around time and cost. Here, we report a nucleic acid testing-based method aiming to detect and discriminate SARS-CoV-2 mutations by combining RT-RPA and CRISPR-Cas12a detecting assays (RRCd). With a detection limit of 10 copies RNA/reaction, RRCd was validated in 194 clinical samples, showing 89% positive predictive agreement and 100% negative predictive agreement, respectively. Critically, using specific crRNAs, representatives of single nucleotide polymorphisms and small deletions in SARS-CoV-2 VOCs including N501Y, T478K and ΔH69-V70 were discriminated by RRCd, demonstrating 100% specificity in clinical samples with Ct < 33. The method completes within 65 min and could offer visible results without using any electrical devices, which probably facilitate point-of-care testing of SARS-CoV-2 variants and other epidemic viruses.
科研通智能强力驱动
Strongly Powered by AbleSci AI